Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 450

1.

Cells of myeloid origin partly mediate the association between psoriasis severity and coronary plaque.

Teague HL, Aksentijevich M, Stansky E, Silverman JI, Varghese NJ, Dey AK, Elnabawi Y, Goyal A, Dagur PK, Chen MY, McCoy JP, Playford MP, Hourigan C, Gelfand JM, Mehta NN.

J Invest Dermatol. 2019 Sep 17. pii: S0022-202X(19)33234-8. doi: 10.1016/j.jid.2019.07.724. [Epub ahead of print] No abstract available.

PMID:
31539534
2.

Progressive Neurological Impairment and an Enhancing Brainstem Lesion in a Middle-aged Man.

Gupta S, Damon L, Gelfand JM.

JAMA Neurol. 2019 Sep 16. doi: 10.1001/jamaneurol.2019.3002. [Epub ahead of print] No abstract available.

PMID:
31524939
3.

Prescribing Patterns Associated With Biologic Therapies for Psoriasis from a United States Medical Records Database

Noe MH, Shin DB, Doshi JA, Margolis DJ, Gelfand JM.

J Drugs Dermatol. 2019 Aug 1;18(8):745-750.

4.

Association of aortic vascular uptake of 18FDG by PET/CT and aortic wall thickness by MRI in psoriasis: a prospective observational study.

Groenendyk JW, Shukla P, Dey AK, Elnabawi YA, Aksentijevich M, Choi H, Genovese LD, Harrington CL, Natarajan B, Goyal A, Reddy AS, Rodante J, Kabbany MT, Sadek A, Al Najafi M, Playford MP, Joshi AA, Ahlman MA, Gelfand JM, Bluemke DA, Mehta NN.

Eur J Nucl Med Mol Imaging. 2019 Aug 5. doi: 10.1007/s00259-019-04454-w. [Epub ahead of print]

PMID:
31385013
5.

Dupilumab shows long-term safety and efficacy in moderate-to-severe atopic dermatitis patients enrolled in a phase 3 open-label extension study.

Deleuran M, Thaçi D, Beck LA, de Bruin-Weller M, Blauvelt A, Forman S, Bissonnette R, Reich K, Soong W, Hussain I, Foley P, Hide M, Bouaziz JD, Gelfand JM, Sher L, Schuttelaar MLA, Wang C, Chen Z, Akinlade B, Gadkari A, Eckert L, Davis JD, Rajadhyaksha M, Staudinger H, Graham NMH, Pirozzi G, Ardeleanu M.

J Am Acad Dermatol. 2019 Jul 30. pii: S0190-9622(19)32465-X. doi: 10.1016/j.jaad.2019.07.074. [Epub ahead of print]

6.

Association of Biologic Therapy With Coronary Inflammation in Patients With Psoriasis as Assessed by Perivascular Fat Attenuation Index.

Elnabawi YA, Oikonomou EK, Dey AK, Mancio J, Rodante JA, Aksentijevich M, Choi H, Keel A, Erb-Alvarez J, Teague HL, Joshi AA, Playford MP, Lockshin B, Choi AD, Gelfand JM, Chen MY, Bluemke DA, Shirodaria C, Antoniades C, Mehta NN.

JAMA Cardiol. 2019 Jul 31. doi: 10.1001/jamacardio.2019.2589. [Epub ahead of print]

PMID:
31365032
7.

Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy.

Elmets CA, Lim HW, Stoff B, Connor C, Cordoro KM, Lebwohl M, Armstrong AW, Davis DMR, Elewski BE, Gelfand JM, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kiselica M, Kivelevitch D, Korman NJ, Kroshinsky D, Leonardi CL, Lichten J, Mehta NN, Paller AS, Parra SL, Pathy AL, Farley Prater EA, Rupani RN, Siegel M, Strober BE, Wong EB, Wu JJ, Hariharan V, Menter A.

J Am Acad Dermatol. 2019 Sep;81(3):775-804. doi: 10.1016/j.jaad.2019.04.042. Epub 2019 Jul 25.

PMID:
31351884
8.

Multiple sclerosis and sarcoidosis: A case for coexistence.

Tyshkov C, Pawate S, Bradshaw MJ, Kimbrough DJ, Chitnis T, Gelfand JM, Ryerson LZ, Kister I.

Neurol Clin Pract. 2019 Jun;9(3):218-227. doi: 10.1212/CPJ.0000000000000629.

PMID:
31341709
9.

A Phase IV, Randomized, Double-Blind, Placebo-Controlled Crossover Study of the Effects of Ustekinumab on Vascular Inflammation in Psoriasis (the VIP-U Trial).

Gelfand JM, Shin DB, Alavi A, Torigian DA, Werner T, Papadopoulos M, Takeshita J, Noe MH, Dey AK, Playford MP, Mehta NN.

J Invest Dermatol. 2019 Jul 19. pii: S0022-202X(19)32537-0. doi: 10.1016/j.jid.2019.07.679. [Epub ahead of print]

PMID:
31326395
10.

Exploratory proteomic analysis implicates the alternative complement cascade in primary CNS vasculitis.

Mandel-Brehm C, Retallack H, Knudsen GM, Yamana A, Hajj-Ali RA, Calabrese LH, Tihan T, Sample HA, Zorn KC, Gorman MP, Madan Cohen J, Sreih AG, Marcus JF, Josephson SA, Douglas VC, Gelfand JM, Wilson MR, DeRisi JL.

Neurology. 2019 Jul 30;93(5):e433-e444. doi: 10.1212/WNL.0000000000007850. Epub 2019 Jul 3.

PMID:
31270218
11.

Pain Is a Common and Burdensome Symptom of Atopic Dermatitis in United States Adults.

Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Chiesa Fuxench ZC, Simpson EL, Ong PY.

J Allergy Clin Immunol Pract. 2019 Jun 20. pii: S2213-2198(19)30555-0. doi: 10.1016/j.jaip.2019.05.055. [Epub ahead of print]

PMID:
31228619
12.

Clinical Metagenomic Sequencing for Diagnosis of Meningitis and Encephalitis.

Wilson MR, Sample HA, Zorn KC, Arevalo S, Yu G, Neuhaus J, Federman S, Stryke D, Briggs B, Langelier C, Berger A, Douglas V, Josephson SA, Chow FC, Fulton BD, DeRisi JL, Gelfand JM, Naccache SN, Bender J, Dien Bard J, Murkey J, Carlson M, Vespa PM, Vijayan T, Allyn PR, Campeau S, Humphries RM, Klausner JD, Ganzon CD, Memar F, Ocampo NA, Zimmermann LL, Cohen SH, Polage CR, DeBiasi RL, Haller B, Dallas R, Maron G, Hayden R, Messacar K, Dominguez SR, Miller S, Chiu CY.

N Engl J Med. 2019 Jun 13;380(24):2327-2340. doi: 10.1056/NEJMoa1803396.

13.

Factors Influencing Sleep Difficulty and Sleep Quantity in the Citizen Pscientist Psoriatic Cohort.

Smith MP, Ly K, Thibodeaux Q, Weerasinghe T, Beck K, Shankle L, Armstrong AW, Boas M, Bridges A, Doris F, Gelfand JM, Lafoy B, Orbai AM, Takeshita J, Truman S, Wan MT, Wu JJ, Siegel MP, Bell SJ, Bhutani T, Liao W.

Dermatol Ther (Heidelb). 2019 Sep;9(3):511-523. doi: 10.1007/s13555-019-0306-1. Epub 2019 Jun 8.

14.

Patient-reported outcomes of adalimumab, phototherapy, and placebo in the Vascular Inflammation in Psoriasis Trial: A randomized controlled study.

Noe MH, Wan MT, Shin DB, Armstrong AW, Duffin KC, Chiesa Fuxench ZC, Kalb RE, Menter A, Simpson EL, Takeshita J, Tyring SK, Van Voorhees AS, Mehta NN, Gelfand JM.

J Am Acad Dermatol. 2019 Oct;81(4):923-930. doi: 10.1016/j.jaad.2019.05.080. Epub 2019 Jun 1.

PMID:
31163241
15.

GABAA receptor autoimmunity: A multicenter experience.

O'Connor K, Waters P, Komorowski L, Zekeridou A, Guo CY, Mgbachi VC, Probst C, Mindorf S, Teegen B, Gelfand JM, Geschwind MD, Lennon V, Pittock SJ, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2019 Apr 4;6(3):e552. doi: 10.1212/NXI.0000000000000552. eCollection 2019 May.

16.

Responsiveness of the EuroQol 5-Dimension 3-Level instrument, Dermatology Life Quality Index (DLQI) and DLQI-Relevant for patients with psoriasis in the U.S.A.

Barbieri JS, Gelfand JM.

Br J Dermatol. 2019 May 17. doi: 10.1111/bjd.18142. [Epub ahead of print] No abstract available.

PMID:
31102266
17.

Lack of association of biologic therapy for psoriasis with psychiatric illness: An electronic medical records cohort study.

Margolis DJ, Shin D, Noe MH, Wan MT, Bhate K, Wang S, Hoffstad O, Takeshita J, Gelfand JM.

J Am Acad Dermatol. 2019 Sep;81(3):709-716. doi: 10.1016/j.jaad.2019.04.055. Epub 2019 May 2.

PMID:
31054973
18.

Validation and Interpretation of Short Form 12 and Comparison with Dermatology Life Quality Index in Atopic Dermatitis in Adults.

Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Ong PY, Chiesa Fuxench ZC, Simpson EL.

J Invest Dermatol. 2019 Oct;139(10):2090-2097.e3. doi: 10.1016/j.jid.2019.03.1152. Epub 2019 Apr 19.

PMID:
31009616
19.

Influence of "Not Relevant" Responses on the Dermatology Life Quality Index (DLQI) for Patients With Psoriasis in the United States.

Barbieri JS, Gelfand JM.

JAMA Dermatol. 2019 Jun 1;155(6):743-745. doi: 10.1001/jamadermatol.2018.5655. No abstract available.

PMID:
30969312
20.

Burden of illness in adults with atopic dermatitis: Analysis of National Health and Wellness Survey data from France, Germany, Italy, Spain, and the United Kingdom.

Eckert L, Gupta S, Gadkari A, Mahajan P, Gelfand JM.

J Am Acad Dermatol. 2019 Jul;81(1):187-195. doi: 10.1016/j.jaad.2019.03.037. Epub 2019 Mar 21.

21.

Distribution of atopic dermatitis lesions in United States adults.

Silverberg JI, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Ong PY, Chiesa Fuxench ZC, Simpson EL, Gelfand JM.

J Eur Acad Dermatol Venereol. 2019 Jul;33(7):1341-1348. doi: 10.1111/jdv.15574. Epub 2019 Apr 15.

PMID:
30883885
22.

Engaging the Patient's Perspective in Clinical Trials Research.

Hefele B, Langan SM, Pollins K, Gelfand JM.

J Invest Dermatol. 2019 Jun;139(6):1217-1220. doi: 10.1016/j.jid.2019.02.028. Epub 2019 Mar 14. No abstract available.

23.

Association of Continuous Assessment of Step Count by Remote Monitoring With Disability Progression Among Adults With Multiple Sclerosis.

Block VJ, Bove R, Zhao C, Garcha P, Graves J, Romeo AR, Green AJ, Allen DD, Hollenbach JA, Olgin JE, Marcus GM, Pletcher MJ, Cree BAC, Gelfand JM.

JAMA Netw Open. 2019 Mar 1;2(3):e190570. doi: 10.1001/jamanetworkopen.2019.0570.

24.

Silent progression in disease activity-free relapsing multiple sclerosis.

University of California, San Francisco MS-EPIC Team, Cree BAC, Hollenbach JA, Bove R, Kirkish G, Sacco S, Caverzasi E, Bischof A, Gundel T, Zhu AH, Papinutto N, Stern WA, Bevan C, Romeo A, Goodin DS, Gelfand JM, Graves J, Green AJ, Wilson MR, Zamvil SS, Zhao C, Gomez R, Ragan NR, Rush GQ, Barba P, Santaniello A, Baranzini SE, Oksenberg JR, Henry RG, Hauser SL.

Ann Neurol. 2019 May;85(5):653-666. doi: 10.1002/ana.25463. Epub 2019 Mar 30.

25.

Neutrophil Subsets, Platelets, and Vascular Disease in Psoriasis.

Teague HL, Varghese NJ, Tsoi LC, Dey AK, Garshick MS, Silverman JI, Baumer Y, Harrington CL, Stempinski E, Elnabawi YA, Dagur PK, Cui K, Tunc I, Seifuddin F, Joshi AA, Stansky E, Purmalek MM, Rodante JA, Keel A, Aridi TZ, Carmona-Rivera C, Sanda GE, Chen MY, Pirooznia M, McCoy JP Jr, Gelfand JM, Zhao K, Gudjonsson JE, Playford MP, Kaplan MJ, Berger JS, Mehta NN.

JACC Basic Transl Sci. 2019 Feb 25;4(1):1-14. doi: 10.1016/j.jacbts.2018.10.008. eCollection 2019 Feb.

26.

Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10.

Noe MH, Rosenbach M, Hubbard RA, Mostaghimi A, Cardones AR, Chen JK, Cotliar J, Davis MDP, Dominguez A, Fox LP, Hughey LC, Kaffenberger BH, Kroshinsky D, Kwong BY, Miller DD, Musiek A, Ortega-Loayza AG, Sharon VR, Shinkai K, Summers EM, Wanat KA, Wetter DA, Worswick S, Margolis DJ, Gelfand JM, Micheletti RG.

JAMA Dermatol. 2019 Apr 1;155(4):448-454. doi: 10.1001/jamadermatol.2018.5605. Erratum in: JAMA Dermatol. 2019 Jul 31;:.

PMID:
30840032
27.

Symptoms and diagnosis of anxiety and depression in atopic dermatitis in U.S. adults.

Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Ong PY, Chiesa Fuxench ZC, Simpson EL.

Br J Dermatol. 2019 Sep;181(3):554-565. doi: 10.1111/bjd.17683. Epub 2019 Mar 5.

PMID:
30838645
28.

Dual blockade of CXCL12-CXCR4 and PD-1-PD-L1 pathways prolongs survival of ovarian tumor-bearing mice by prevention of immunosuppression in the tumor microenvironment.

Zeng Y, Li B, Liang Y, Reeves PM, Qu X, Ran C, Liu Q, Callahan MV, Sluder AE, Gelfand JA, Chen H, Poznansky MC.

FASEB J. 2019 May;33(5):6596-6608. doi: 10.1096/fj.201802067RR. Epub 2019 Feb 25.

PMID:
30802149
29.

Clinic to in-home telemedicine reduces barriers to care for patients with MS or other neuroimmunologic conditions.

Bove R, Garcha P, Bevan CJ, Crabtree-Hartman E, Green AJ, Gelfand JM.

Neurol Neuroimmunol Neuroinflamm. 2018 Oct 2;5(6):e505. doi: 10.1212/NXI.0000000000000505. eCollection 2018 Nov.

30.

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.

Menter A, Strober BE, Kaplan DH, Kivelevitch D, Prater EF, Stoff B, Armstrong AW, Connor C, Cordoro KM, Davis DMR, Elewski BE, Gelfand JM, Gordon KB, Gottlieb AB, Kavanaugh A, Kiselica M, Korman NJ, Kroshinsky D, Lebwohl M, Leonardi CL, Lichten J, Lim HW, Mehta NN, Paller AS, Parra SL, Pathy AL, Rupani RN, Siegel M, Wong EB, Wu JJ, Hariharan V, Elmets CA.

J Am Acad Dermatol. 2019 Apr;80(4):1029-1072. doi: 10.1016/j.jaad.2018.11.057. Epub 2019 Feb 13. Review.

PMID:
30772098
31.

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities.

Elmets CA, Leonardi CL, Davis DMR, Gelfand JM, Lichten J, Mehta NN, Armstrong AW, Connor C, Cordoro KM, Elewski BE, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kivelevitch D, Kiselica M, Korman NJ, Kroshinsky D, Lebwohl M, Lim HW, Paller AS, Parra SL, Pathy AL, Prater EF, Rupani R, Siegel M, Stoff B, Strober BE, Wong EB, Wu JJ, Hariharan V, Menter A.

J Am Acad Dermatol. 2019 Apr;80(4):1073-1113. doi: 10.1016/j.jaad.2018.11.058. Epub 2019 Feb 13. Review.

PMID:
30772097
32.

Racial Differences in Perceptions of Psoriasis Therapies: Implications for Racial Disparities in Psoriasis Treatment.

Takeshita J, Eriksen WT, Raziano VT, Bocage C, Hur L, Shah RV, Gelfand JM, Barg FK.

J Invest Dermatol. 2019 Aug;139(8):1672-1679.e1. doi: 10.1016/j.jid.2018.12.032. Epub 2019 Feb 6.

PMID:
30738054
33.

Coronary artery plaque characteristics and treatment with biologic therapy in severe psoriasis: results from a prospective observational study.

Elnabawi YA, Dey AK, Goyal A, Groenendyk JW, Chung JH, Belur AD, Rodante J, Harrington CL, Teague HL, Baumer Y, Keel A, Playford MP, Sandfort V, Chen MY, Lockshin B, Gelfand JM, Bluemke DA, Mehta NN.

Cardiovasc Res. 2019 Mar 15;115(4):721-728. doi: 10.1093/cvr/cvz009.

34.

pRNFL as a marker of disability worsening in the medium/long term in patients with MS.

Cordano C, Nourbakhsh B, Devereux M, Damotte V, Bennett D, Hauser SL, Cree BAC, Gelfand JM, Green AJ.

Neurol Neuroimmunol Neuroinflamm. 2018 Dec 21;6(2):e533. doi: 10.1212/NXI.0000000000000533. eCollection 2019 Mar. No abstract available.

35.

Atopic Dermatitis in US Adults: From Population to Health Care Utilization.

Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Ong PY, Chiesa Fuxench Z, Simpson EL.

J Allergy Clin Immunol Pract. 2019 May - Jun;7(5):1524-1532.e2. doi: 10.1016/j.jaip.2019.01.005. Epub 2019 Jan 14.

PMID:
30654197
36.

Prevalence of clinically significant incidental findings by whole-body fludeoxyglucose F 18 positron emission tomography/computed tomography scanning in moderate-to-severe psoriasis patients participating in clinical trials.

Wan MT, Torigian DA, Alavi A, Alvarez J, Chiesa Fuxench ZC, Noe MH, Papadopoulos M, Shin DB, Takeshita J, Werner TJ, Mehta NN, Gelfand JM.

J Am Acad Dermatol. 2019 Jun;80(6):1630-1639. doi: 10.1016/j.jaad.2019.01.008. Epub 2019 Jan 14.

PMID:
30654078
37.

Effectiveness of Online vs In-Person Care for Adults With Psoriasis: A Randomized Clinical Trial.

Armstrong AW, Chambers CJ, Maverakis E, Cheng MY, Dunnick CA, Chren MM, Gelfand JM, Wong DJ, Gibbons BM, Gibbons CM, Torres J, Steel AC, Wang EA, Clark CM, Singh S, Kornmehl HA, Wilken R, Florek AG, Ford AR, Ma C, Ehsani-Chimeh N, Boddu S, Fujita M, Young PM, Rivas-Sanchez C, Cornejo BI, Serna LC, Carlson ER, Lane CJ.

JAMA Netw Open. 2018 Oct 5;1(6):e183062. doi: 10.1001/jamanetworkopen.2018.3062.

38.

Photoinactivation of Neisseria gonorrhoeae: A Paradigm-Changing Approach for Combating Antibiotic-Resistant Gonococcal Infection.

Wang Y, Ferrer-Espada R, Baglo Y, Goh XS, Held KD, Grad YH, Gu Y, Gelfand JA, Dai T.

J Infect Dis. 2019 Jul 31;220(5):873-881. doi: 10.1093/infdis/jiz018.

PMID:
30629196
39.

Measurement Properties of the Hospital Anxiety and Depression Scale Used in Atopic Dermatitis in Adults.

Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Ong PY, Chiesa Fuxench ZC, Simpson EL.

J Invest Dermatol. 2019 Jun;139(6):1388-1391. doi: 10.1016/j.jid.2018.11.029. Epub 2018 Dec 17. No abstract available.

PMID:
30571970
40.

Association Between Oxidation-Modified Lipoproteins and Coronary Plaque in Psoriasis.

Sorokin AV, Kotani K, Elnabawi YA, Dey AK, Sajja AP, Yamada S, Ueda M, Harrington CL, Baumer Y, Rodante JA, Gelfand JM, Chen MY, Joshi AA, Playford MP, Remaley AT, Mehta NN.

Circ Res. 2018 Nov 9;123(11):1244-1254. doi: 10.1161/CIRCRESAHA.118.313608.

PMID:
30571459
41.

Health Utility Scores of Atopic Dermatitis in US Adults.

Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Ong PY, Fuxench ZC, Simpson EL.

J Allergy Clin Immunol Pract. 2019 Apr;7(4):1246-1252.e1. doi: 10.1016/j.jaip.2018.11.043. Epub 2018 Dec 8.

42.

Online Care Versus In-Person Care for Improving Quality of Life in Psoriasis: A Randomized Controlled Equivalency Trial.

Armstrong AW, Ford AR, Chambers CJ, Maverakis E, Dunnick CA, Chren MM, Gelfand JM, Gibbons CM, Gibbons BM, Lane CJ.

J Invest Dermatol. 2019 May;139(5):1037-1044. doi: 10.1016/j.jid.2018.09.039. Epub 2018 Nov 24.

43.

A young man with numbness in arms and legs: From the National Multiple Sclerosis Society Case Conference Proceedings.

Romeo AR, Lisak RP, Meltzer E, Fox EJ, Melamed E, Lucas A, Freeman L, Frohman TC, Costello K, Zamvil SS, Frohman EM, Gelfand JM.

Neurol Neuroimmunol Neuroinflamm. 2018 Oct 23;5(6):e509. doi: 10.1212/NXI.0000000000000509. eCollection 2018 Nov. No abstract available.

44.

Antimicrobial Photodynamic Inactivation Mediated by Tetracyclines in Vitro and in Vivo: Photochemical Mechanisms and Potentiation by Potassium Iodide.

Xuan W, He Y, Huang L, Huang YY, Bhayana B, Xi L, Gelfand JA, Hamblin MR.

Sci Rep. 2018 Nov 20;8(1):17130. doi: 10.1038/s41598-018-35594-y.

45.

Chronic Stress-Related Neural Activity Associates With Subclinical Cardiovascular Disease in Psoriasis: A Prospective Cohort Study.

Goyal A, Dey AK, Chaturvedi A, Elnabawi YA, Aberra TM, Chung JH, Belur AD, Groenendyk JW, Lerman JB, Rivers JP, Rodante JA, Harrington CL, Varghese NJ, Sanda GE, Baumer Y, Sorokin AV, Teague HL, Genovese LD, Natarajan B, Joshi AA, Playford MP, Bluemke DA, Chen MY, Alavi A, Pitman RK, Powell-Wiley TM, Tawakol A, Gelfand JM, Mehta NN.

JACC Cardiovasc Imaging. 2018 Nov 8. pii: S1936-878X(18)30920-3. doi: 10.1016/j.jcmg.2018.08.038. [Epub ahead of print]

PMID:
30448131
46.

Evaluation of the Dermatology Life Quality Index scoring modification, the DLQI-R score, in two independent populations.

Barbieri JS, Gelfand JM.

Br J Dermatol. 2019 Apr;180(4):939-940. doi: 10.1111/bjd.17419. Epub 2018 Dec 19. No abstract available.

PMID:
30430547
47.

Brief Exposure of Skin to Near-Infrared Laser Modulates Mast Cell Function and Augments the Immune Response.

Kimizuka Y, Katagiri W, Locascio JJ, Shigeta A, Sasaki Y, Shibata M, Morse K, Sîrbulescu RF, Miyatake M, Reeves P, Suematsu M, Gelfand J, Brauns T, Poznansky MC, Tsukada K, Kashiwagi S.

J Immunol. 2018 Dec 15;201(12):3587-3603. doi: 10.4049/jimmunol.1701687. Epub 2018 Nov 12.

PMID:
30420435
48.

Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population.

Chiesa Fuxench ZC, Block JK, Boguniewicz M, Boyle J, Fonacier L, Gelfand JM, Grayson MH, Margolis DJ, Mitchell L, Silverberg JI, Schwartz L, Simpson EL, Ong PY.

J Invest Dermatol. 2019 Mar;139(3):583-590. doi: 10.1016/j.jid.2018.08.028. Epub 2018 Oct 30.

49.

Influenza Vaccination Rates in Adults with Psoriasis Compared to Adults with Other Chronic Diseases.

Noe MH, Shin DB, Hubbard RA, Hennessy S, Gelfand JM.

J Invest Dermatol. 2019 Feb;139(2):473-475. doi: 10.1016/j.jid.2018.09.012. Epub 2018 Oct 10. No abstract available.

50.

Association Between Aortic Vascular Inflammation and Coronary Artery Plaque Characteristics in Psoriasis.

Joshi AA, Lerman JB, Dey AK, Sajja AP, Belur AD, Elnabawi YA, Rodante JA, Aberra TM, Chung J, Salahuddin T, Natarajan B, Dave J, Goyal A, Groenendyk JW, Rivers JP, Baumer Y, Teague HL, Playford MP, Bluemke DA, Ahlman MA, Chen MY, Gelfand JM, Mehta NN.

JAMA Cardiol. 2018 Oct 1;3(10):949-956. doi: 10.1001/jamacardio.2018.2769.

Supplemental Content

Loading ...
Support Center